124 related articles for article (PubMed ID: 25446513)
1. Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution.
Wang Q; Yao G; Dong P; Gong Z; Li G; Zhang K; Wu C
Eur J Pharm Sci; 2015 Jan; 66():148-56. PubMed ID: 25446513
[TBL] [Abstract][Full Text] [Related]
2. Dissolving Microneedle Arrays with Optimized Needle Geometry for Transcutaneous Immunization.
Li Y; Hu X; Dong Z; Chen Y; Zhao W; Wang Y; Zhang L; Chen M; Wu C; Wang Q
Eur J Pharm Sci; 2020 Aug; 151():105361. PubMed ID: 32422374
[TBL] [Abstract][Full Text] [Related]
3. Novel strategy for immunomodulation: Dissolving microneedle array encapsulating thymopentin fabricated by modified two-step molding technology.
Lin S; Cai B; Quan G; Peng T; Yao G; Zhu C; Wu Q; Ran H; Pan X; Wu C
Eur J Pharm Biopharm; 2018 Jan; 122():104-112. PubMed ID: 29042238
[TBL] [Abstract][Full Text] [Related]
4. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics.
Zhang L; Li Y; Wei F; Liu H; Wang Y; Zhao W; Dong Z; Ma T; Wang Q
AAPS PharmSciTech; 2020 Nov; 22(1):1. PubMed ID: 33215299
[TBL] [Abstract][Full Text] [Related]
5. A novel scalable fabrication process for the production of dissolving microneedle arrays.
Chen H; Wu B; Zhang M; Yang P; Yang B; Qin W; Wang Q; Wen X; Chen M; Quan G; Pan X; Wu C
Drug Deliv Transl Res; 2019 Feb; 9(1):240-248. PubMed ID: 30341765
[TBL] [Abstract][Full Text] [Related]
6. Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array.
Lin S; Quan G; Hou A; Yang P; Peng T; Gu Y; Qin W; Liu R; Ma X; Pan X; Liu H; Wang L; Wu C
J Control Release; 2019 Jul; 306():69-82. PubMed ID: 31145948
[TBL] [Abstract][Full Text] [Related]
7. Efficient fabrication of thermo-stable dissolving microneedle arrays for intradermal delivery of influenza whole inactivated virus vaccine.
Lee J; Beukema M; Zaplatynska OA; O'Mahony C; Hinrichs WLJ; Huckriede ALW; Bouwstra JA; van der Maaden K
Biomater Sci; 2023 Oct; 11(20):6790-6800. PubMed ID: 37622228
[TBL] [Abstract][Full Text] [Related]
8. Current advances in the fabrication of microneedles for transdermal delivery.
Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs.
Chu LY; Choi SO; Prausnitz MR
J Pharm Sci; 2010 Oct; 99(10):4228-38. PubMed ID: 20737630
[TBL] [Abstract][Full Text] [Related]
10. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
[TBL] [Abstract][Full Text] [Related]
11. Engineering of an automated nano-droplet dispensing system for fabrication of antigen-loaded dissolving microneedle arrays.
Lee J; van der Maaden K; Gooris G; O'Mahony C; Jiskoot W; Bouwstra J
Int J Pharm; 2021 May; 600():120473. PubMed ID: 33737094
[TBL] [Abstract][Full Text] [Related]
12. [Preparation and transdermal effect of a tip-loaded bubble-soluble microneedle].
Zhu L; Zhuang J; Zhao Z; Huang Y; Sun J; Liu F; Xue Q; Wu D
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2281-2291. PubMed ID: 35786479
[TBL] [Abstract][Full Text] [Related]
13. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
14. A new computational method of modeling and evaluation of dissolving microneedle for drug delivery applications: Extension to theoretical modeling of a novel design of microneedle (array in array) for efficient drug delivery.
Zoudani EL; Soltani M
Eur J Pharm Sci; 2020 Jul; 150():105339. PubMed ID: 32315773
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
16. Analyzing polymeric matrix for fabrication of a biodegradable microneedle array to enhance transdermal delivery.
Hwa KY; Chang VHS; Cheng YY; Wang YD; Jan PS; Subramani B; Wu MJ; Wang BK
Biomed Microdevices; 2017 Sep; 19(4):84. PubMed ID: 28929244
[TBL] [Abstract][Full Text] [Related]
17. Rapid fabrication method of a microneedle mold with controllable needle height and width.
Lin YH; Lee IC; Hsu WC; Hsu CH; Chang KP; Gao SS
Biomed Microdevices; 2016 Oct; 18(5):85. PubMed ID: 27565822
[TBL] [Abstract][Full Text] [Related]
18. Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using dissolvable microneedle arrays.
Yerneni SS; Yalcintas EP; Smith JD; Averick S; Campbell PG; Ozdoganlar OB
Acta Biomater; 2022 Sep; 149():198-212. PubMed ID: 35809788
[TBL] [Abstract][Full Text] [Related]
19. Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles.
Dangol M; Yang H; Li CG; Lahiji SF; Kim S; Ma Y; Jung H
J Control Release; 2016 Feb; 223():118-125. PubMed ID: 26732554
[TBL] [Abstract][Full Text] [Related]
20. Chemical imaging analysis of active pharmaceutical ingredient in dissolving microneedle arrays by Raman spectroscopy.
Ando D; Miyazaki T; Yamamoto E; Koide T; Izutsu KI
Drug Deliv Transl Res; 2022 Feb; 12(2):426-434. PubMed ID: 34431066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
